| Name | Title | Contact Details |
|---|---|---|
Christina Ackermann |
EVP, General Counsel | Profile |
Isabelle Lefebvre |
Vice President Global Regulatory Affairs | Profile |
VintaBio is a life sciences company that specializes in customized process development, GMP manufacturing, and quality control services for cell and gene therapies.
CoGenesys is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Recursion Pharmaceuticals has developed a powerful drug discovery platform involving millions of rapid, automated experiments and analysis to discover new therapeutics.
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in Greater China and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. The company`s Series A round was led by C-Bridge Capital, a top-tier China healthcare private equity firm, with US $800 million under management.
Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.